XERIS PHARMACEUTICALS INC — key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2020)

$20.2M

Net Income/Loss (FY2020)

-$91.1M

Total Assets (FY2020)

$159.2M

Total Equity (FY2020)

$33.8M

Cash Flows from Operating Activities (FY2020)

-$80.6M

Source: XERIS PHARMACEUTICALS INC 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.